Core Insights - Precigen, Inc. is set to present at the 44th Annual J.P. Morgan Healthcare Conference from January 12–15, 2026, with CEO Helen Sabzevari scheduled to speak on January 15, 2026, at 7:30 AM PT [1] - Dr. Sabzevari will also participate in a fireside chat hosted by Eversana on January 12, 2026, at 10:30 AM PT during the Biotech Showcase [2] - Precigen focuses on developing innovative precision medicines for difficult-to-treat diseases, with a strong pipeline in immuno-oncology, autoimmune disorders, and infectious diseases [3] Company Overview - Precigen, Inc. specializes in advancing precision medicines aimed at addressing high unmet patient needs [3] - The company is committed to moving scientific breakthroughs from proof-of-concept to commercialization [3] - Precigen is developing a robust pipeline of differentiated therapies across its core therapeutic areas [3]